BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 8774645)

  • 1. Peripheral infusion ports for central venous access in patients with gynecologic malignancies.
    Cunningham MJ; Collins MB; Kredentser DC; Malfetano JH
    Gynecol Oncol; 1996 Mar; 60(3):397-9. PubMed ID: 8774645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term experience with a totally implanted catheter system in gynecologic oncologic patients.
    Koonings PP; Given FT
    J Am Coll Surg; 1994 Feb; 178(2):164-6. PubMed ID: 8173727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experience with the intravenous totally implanted port in patients with gynecologic malignancies.
    Nelson BE; Mayer AR; Tseng PC; Schwartz PE
    Gynecol Oncol; 1994 Apr; 53(1):98-102. PubMed ID: 8175028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignancies.
    Subramaniam A; Kim KH; Bryant SA; Kimball KJ; Huh WK; Straughn JM; Estes JM; Alvarez RD
    Gynecol Oncol; 2011 Oct; 123(1):54-7. PubMed ID: 21742372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A peripherally implanted permanent central venous access device.
    Morris P; Buller R; Kendall S; Anderson B
    Obstet Gynecol; 1991 Dec; 78(6):1138-42. PubMed ID: 1945224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Externalized Groshong catheters and Hickman ports for central venous access in gynecologic oncology patients.
    Gleeson NC; Fiorica JV; Mark JE; Pinelli DM; Hoffman MS; Roberts WS; Cavanagh D
    Gynecol Oncol; 1993 Dec; 51(3):372-6. PubMed ID: 8112648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complications related to indwelling caval catheters on a gynecologic oncology service.
    Silver DF; Hempling RE; Recio FO; Piver MS; Eltabbakh GH
    Gynecol Oncol; 1998 Sep; 70(3):329-33. PubMed ID: 9790783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications).
    Pittiruti M; Hamilton H; Biffi R; MacFie J; Pertkiewicz M;
    Clin Nutr; 2009 Aug; 28(4):365-77. PubMed ID: 19464090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insertion of Groshong central venous catheters utilizing fluoroscopic techniques.
    Burnett AF; Lossef SV; Barth KH; Grendys EC; Johnson JC; Barter JF; Barnes WA
    Gynecol Oncol; 1994 Jan; 52(1):69-73. PubMed ID: 8307504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peripheral ports are a new option for central venous access.
    Schuman E; Ragsdale J
    J Am Coll Surg; 1995 Apr; 180(4):456-60. PubMed ID: 7719550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The complications of central venous access systems: a study of 218 patients.
    Torramadé JR; Cienfuegos JA; Hernández JL; Pardo F; Benito C; González J; Balén E; de Villa V
    Eur J Surg; 1993; 159(6-7):323-7. PubMed ID: 8104491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Insertion and management of long-term central venous devices: role of radiologic imaging techniques].
    Capaccioli L; Nistri M; Distante V; Rontini M; Manetti A; Stecco A
    Radiol Med; 1998 Oct; 96(4):369-74. PubMed ID: 9972217
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The fate of 100 prolonged venous access devices.
    Hayward SR; Ledgerwood AM; Lucas CE
    Am Surg; 1990 Sep; 56(9):515-9. PubMed ID: 2393188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
    Quarello F; Forneris G; Borca M; Pozzato M
    J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of thrombosis and infections of central venous catheters and totally implanted access ports in patients treated for cancer.
    Beckers MM; Ruven HJ; Seldenrijk CA; Prins MH; Biesma DH
    Thromb Res; 2010 Apr; 125(4):318-21. PubMed ID: 19640573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis.
    Schwarz RE; Groeger JS; Coit DG
    Cancer; 1997 Apr; 79(8):1635-40. PubMed ID: 9118051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in venous access devices and nursing management strategies.
    Wickham RS
    Nurs Clin North Am; 1990 Jun; 25(2):345-64. PubMed ID: 2110664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An evaluation of Groshong central venous catheters on a gynecologic oncology service.
    Holloway RW; Orr JW
    Gynecol Oncol; 1995 Feb; 56(2):211-7. PubMed ID: 7896188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiologic placement of a low profile implantable venous access port in a pediatric population.
    Nosher JL; Bodner LJ; Ettinger LJ; Siegel RL; Gribbin C; Asch J; Drachtman RA
    Cardiovasc Intervent Radiol; 2001; 24(6):395-9. PubMed ID: 11907746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of venous access device wound complications in patients undergoing paclitaxel chemotherapy for gynecologic malignancies.
    Boulay RM; Olt GJ; Podczaski ES
    Gynecol Oncol; 1998 Aug; 70(2):259-62. PubMed ID: 9740701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.